Viewing nowCrelor 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201903849 · Approved 2019.06.13 · Insurance code 678601360
Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is used as an adjunct to diet in patients with hypercholesterolemia and hyperlipidemia when diet and exercise alone are not sufficient for control. It specifically lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis, particularly in cases of primary hypercholesterolemia, combined hyperlipidemia, and familial hypercholesterolemia. It is also used in children aged 10 to 17 years with elevated LDL cholesterol despite dietary measures, and serves as a dietary adjunct in patients with dysbetalipoproteinemia. Additionally, for adult patients with high sensitive C-reactive protein levels and one or more cardiovascular risk factors, it helps reduce the risk of stroke, myocardial infarction, and coronary artery revascularization. This medication is used to improve cardiovascular health and reduce the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and should continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 mg daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medication at 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Assessment of renal function should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medication is contraindicated in some of these patients.
Age 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. First, individuals with an allergy to any of the components in this medication should not use it. It should not be taken by those with severely impaired liver function or those with unexplained elevated liver enzyme levels. People with muscle disorders or previous muscle problems, as well as those taking the immunosuppressant cyclosporine, should also avoid this medication. Patients with significantly impaired kidney function, pregnant or breastfeeding women, and women of childbearing age who do not use appropriate contraception should not use this medication. In particular, high doses should be avoided in cases where there is a high risk of muscle disease, which includes moderate renal impairment, hypothyroidism, personal or family history of muscle disorders, alcohol dependence, and use of certain medications. This medication contains lactose, so individuals with lactose intolerance or related genetic diseases should not use it. This medication should be used cautiously in those who excessively consume alcohol or have a history of liver disease, and it is advisable to have regular liver function tests before and during treatment. For patients with hypercholesterolemia due to hypothyroidism or nephrotic syndrome, it is safer to treat these underlying conditions before using this medication. If symptoms such as muscle pain or weakness occur, patients should inform their healthcare provider immediately, and muscle enzyme levels should be checked and drug discontinuation considered based on symptoms. In particular, elderly patients, patients with renal impairment, and those with a history of alcohol abuse require careful monitoring during treatment. The use of this medication should be discontinued in cases of severe acute illness or the occurrence of muscle weakness. This medication may affect liver function, so it should be stopped immediately if symptoms of liver damage occur, and patients should be cautious about blood sugar control as there may be a slight increase in diabetes risk. Responses to the drug and the risk of side effects may vary depending on genetic factors, so dosage adjustments may be needed. Rarely, serious skin reactions can occur, so if skin rashes or allergic symptoms appear, medication should be discontinued immediately, and healthcare professionals should be consulted. Drug interactions may occur when combined with other medications, especially with cyclosporine, fibrate drugs, certain antiviral agents, antifungals, and some antibiotics, so caution is required when taking these with this medication. Taking antacids may reduce the absorption of this medication, so it is advisable to space out their administration. Additionally, when used with anticoagulants, blood tests for monitoring coagulation are necessary. This medication should not be used during pregnancy or breastfeeding, and women of childbearing age should use appropriate contraceptive methods. There are no specific detoxifying agents in cases of overdose, so treatment should be symptomatic and liver function and muscle enzyme levels should be monitored periodically. This medication can rarely cause dizziness, so caution is advised when driving or operating machinery. Before taking this medication, it is essential to consult with a healthcare professional to inform them of your health status and any other medications being taken, and to undergo regular tests for safe use.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesic syndrome, memory impairment, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius.
Pink round film-coated tablet
For domestic use - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.